Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza — Breakthrough, Episode 250
In episode 250 of the Xtalks Life Science Podcast, Lonza’s Vice President of Bioprocessing Omar Wahab explains why cell‑culture media is a strategic lever for scalable biologics manufacturing. He argues that early formulation choices influence downstream productivity, product quality, and cost of goods, especially as platforms push toward higher cell densities. Structured experimentation, such as Design of Experiments, and digital data environments are replacing trial‑and‑error, delivering actionable insights for rapid clinical advancement. Wahab also highlights the growing importance of regional biologics hubs, like Singapore, for supply resilience and commercial scale readiness.
Α‑Eleostearic Acid Acts as Senolytic via Ferroptosis
α-eleostearic acid as a senolytic via ferroptosis. Found in high concentrations in Tung oil (which is toxic) and in small amounts in Bitter Melon oil. https://t.co/FSCix3OZtD
Obesity Pills: Orforglipron Outpaces Semaglutide: Next-Gen Oral GLP-1 Agonist Drives Superior Glycemic and Weight Control
The phase 3 ACHIEVE‑3 trial showed that oral orforglipron outperformed oral semaglutide in both glycemic control and weight loss for type 2 diabetes patients. At 52 weeks, the 36 mg dose reduced HbA1c by 1.91% versus 1.47% for semaglutide and achieved an 8.2% weight...
Scientists Pinpoint Gene Transporting Brain‑Boosting Nutrient Queuosine
An international team led by the University of Florida has identified the SLC35F2 gene as the cellular gateway for queuosine, a rare micronutrient linked to brain health and cancer resistance. The discovery resolves a 30‑year mystery and opens new avenues...
Three‑Month Omega‑3 Trial Cuts Stress and Boosts Sleep in Adults
In a double‑blind trial of 64 adults with high stress, daily omega‑3 capsules for three months produced statistically significant improvements in stress, anxiety, depression, sleep quality and everyday memory. The findings, published in the Journal of Affective Disorders, suggest a...
Author Correction: Oncogene Ablation-Resistant Pancreatic Cancer Cells Depend on Mitochondrial Function
Nature issued an author correction on 8 April 2026 for the 2014 study linking oncogene‑ablation‑resistant pancreatic cancer cells to mitochondrial function. The correction fixes a sample‑labeling error in immunoblots shown in Fig. 4a, changing the identifiers from “No. 1/2” to “No. 3/4”. The authors state...
Engineered Immunosuppressive Dendritic Cells Protect Against Cardiac Remodelling
Researchers engineered fibroblast‑activation‑protein (FAP)‑targeted immunosuppressive dendritic cells (iCDCs) that co‑express CTLA4‑Ig, PD‑L1 and IL‑10. In mouse myocardial infarction, ischemia‑reperfusion and pressure‑overload models, a single iCDC infusion markedly improved ejection fraction, reduced ventricular dilation and fibrosis, and extended survival. The therapy...
Subjective and Neurocognitive Profiling of Clinical Doses of 3,4-Methylenedioxymethamphetamine (MDMA) in Healthy Volunteers: Implications for Therapeutic Use
A recent clinical study administered therapeutic doses of MDMA (75‑125 mg) to healthy volunteers and measured both subjective experiences and neurocognitive performance. Participants reported marked increases in empathy, mood elevation, and sociability, with peak effects around 90 minutes and a return to...
Adenosine Surges: A Step Forward in Understanding Antidepressant Actions of Ketamine
A recent Nature study reveals that a single sub‑anesthetic dose of (R,S)-ketamine produces rapid, transient surges of extracellular adenosine in the medial prefrontal cortex, independent of NMDA‑receptor blockade. Using genetically encoded adenosine sensors, the researchers showed that these adenosine spikes...
Novo Nordisk's Explosive Wegovy Pill Launch Draws a New Wave of Patients Into GLP-1 Weight Loss Treatment
Novo Nordisk’s oral Wegovy pill launched in January and has already generated over 600,000 prescriptions within three months, attracting tens of thousands of new patients who previously avoided GLP‑1 injections. The drug is priced at $149‑$299 per month, markedly lower...
Turmeric‑Ginger Coating Doubles Bone Bonding, Cuts Bacteria, Cancer Cells
Turmeric and ginger extract applied to titanium implants can double bone bonding in six weeks, eliminate 92% of surface bacteria, and sharply reduce cancer-causing cells, offering a promising advance for joint replacement and bone cancer patients. biomaterials
University of Arizona Launches $12 Million Rapamycin Clinical Trial
The University of Arizona’s R. Ken Coit College of Pharmacy is launching a double‑blind, randomized Phase 3 clinical trial to test low‑dose rapamycin’s ability to boost resilience and immune function in adults aged 65 and older. The six‑year study, funded by a...
Molecular 'Leash' Measures Force-Sensing Protein Activation at About 15 Piconewtons
Researchers at the National University of Singapore engineered a DNA‑based molecular leash that pulls directly on the mechanosensitive ion channel Piezo1, allowing forces as low as 15 piconewtons to be applied with nanometer precision. Real‑time calcium fluorescence showed that Piezo1...
Shingles Vaccine Beats Geroscience in Reducing Dementia
a different take: the shingles vaccine lowers dementia and all cause mortality and it’s targeted to a specific virus, not the process of aging so far the data say the score is shingles vaccine 1, geroscience hypothesis 0 and I could say the...
Scientists Achieve Major Breakthrough in Safe, Reversible Male Contraception
A multinational research team announced a breakthrough in male contraception: a non‑hormonal, reversible pill that achieved 95% efficacy in Phase‑III trials. The compound, which temporarily blocks sperm maturation, proved safe across a diverse cohort with no reported hormonal side effects....
Long-Term Cardiac Amyloidosis Survival Benefits Seen in Extension Acoramidis Trial
The open‑label extension of the ATTRibute‑CM trial demonstrated that the transthyretin stabilizer acoramidis (Attruby) delivers sustained survival benefits out to 54 months in patients with cardiac amyloidosis. Participants who began acoramidis early and remained on therapy showed markedly lower all‑cause...
Insmed Discontinues Development of Skin Condition Drug After Mid-Stage Study Miss
Insmed announced it will discontinue development of brensocatib, its investigational therapy for hidradenitis suppurativa, after the drug failed to meet the primary efficacy endpoint in a mid‑stage trial. The study aimed to reduce painful nodules in patients with the chronic...
FDA Approves First Generic Dapagliflozin to Reduce HF Hospitalization Risk in Type 2 Diabetes
The FDA has approved the first generic dapagliflozin tablets, expanding access to the SGLT2 inhibitor that lowers heart‑failure hospitalizations in type‑2 diabetes. The generics match the branded product’s safety and efficacy profile, offering a lower‑cost alternative to Farxiga. This approval...
Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II
The TRISCEND II trial shows transcatheter tricuspid valve replacement (TTVR) remains safe and improves quality of life at two years. A post‑hoc crossover analysis suggests a mortality advantage for patients receiving the Edwards Evoque device versus those who never received TTVR. While...
AlpE Combo: New Tuberculosis Treatment Breakthrough
An international research team has introduced AlpE, a novel combination of Alpibectir and ethionamide, that dramatically shortens tuberculosis therapy and boosts efficacy against drug‑resistant strains. Alpibectir, a new class of mycobacterial enzyme inhibitor, works synergistically with ethionamide to disrupt cell‑wall...
Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate
Retatrutide, a next‑generation GLP‑1/GIP/Glucagon agonist, appears to cause less nausea than semaglutide while delivering comparable weight‑loss efficacy, but early data show a modest increase in resting heart rate. Patient anecdotes highlight typical GLP‑1 side effects—transient nausea, bowel habit shifts, occasional...
Funding Hurdles Stall Needed Multi‑site BPC‑157 Trial
I can’t see any reason why a proper multi site RCT of BPC157 done by a few independent groups wouldn’t help clarify any real vs placebo effects. The challenge: no one wants to pony up the $ (more like $$$$...
Plant Tissue Culture Constantly Reveals Surprising Cellular Tricks
Coolest part of plant tissue culture is that no matter how much experience you have, you will always learn something new about the strange things plant bits do when given some molecular encouragement.
Neurocrine Grows in Endocrinology, Rare Disease with $2.9B Soleno Buyout
Neurocrine Biosciences announced a $2.9 billion cash acquisition of Soleno Therapeutics, adding the FDA‑approved Vykat XR for Prader‑Willi syndrome to its portfolio. The deal also brings together Neurocrine’s existing marketed drugs Ingrezza and Crenessity, which together generated roughly $2.8 billion in 2025 sales....
Conjugated PUFAs Target Senescent Cells
Polyunsaturated lipid senolytics exploit a ferroptotic vulnerability in senescent cells “ Conjugated PUFAs α-ESA and its methyl ester selectively eliminate diverse senescent cells… These lipid senolytics reduce tissue senescence and extend health span in aged mice” 👉 Lipid peroxidation underlies selective vulnerability...
Hair‑Loss Pill Redefines Masculinity and Aging
The Hair-Loss Drug Rewriting the Rules of Masculinity A pill to cure baldness is changing the way men age — and how they see themselves. https://t.co/4OiLpmOwGR https://t.co/YQLBx61gVT
CRISPR Gene Edit Cuts LDL by 49% in Early Trial, Offering Durable Cholesterol Solution
A CRISPR Therapeutics‑funded study of a single‑dose gene edit that disables the liver gene ANGPTL3 lowered LDL cholesterol by 49% and triglycerides by 55% in a 15‑patient trial. Results published in the New England Journal of Medicine last November have...
Follistatin: Dual Weapon Against Cancer and Muscle Loss
Follistatin protein, which plays a key role both in inhibiting tumors and promoting muscle tissue growth. https://t.co/OebCo6FSI7
KLF5 Drives Pancreatic Cancer Spread via Gene Rewiring
A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, helping tumors grow and invade new...
What This AI Epitope Library Means for Vaccines, Immunotherapy and Biosensors
CIC biomaGUNE, together with Multiverse Computing, has launched epiGPTope, an AI‑driven platform that designs and classifies synthetic epitopes at scale. The system can generate a library of hundreds of thousands of protein fragments and predict whether they originate from viruses...
Fatty Acids Target and Eliminate Aging “Zombie” Cells
NEW STUDY finds certain fatty acids selectively kill senescent "zombie" cells. The molecules exploit a fundamental biophysical weakness in senescent cells, a totally new approach. Could we simply consume these moleculs to treat aging? ...🧵 https://t.co/EceCAfdlvz
New Cytotoxic Targets Unveiled at AACR26
Time to head off the beaten track at #AACR26 with our latest preview exploring novel targets and cytotoxics. The long climb up the hill may be worth it for some of them: https://t.co/l9tkdWvpuF https://t.co/M5B3RTW1wf
Navigating the Frontiers of Advanced Therapeutics and Operational Excellence
In 2026 the biopharma sector is juggling rapid advances in emerging modalities—viral vectors, multispecific antibodies and nucleic‑acid therapies—with heightened operational discipline. Companies are deploying patient‑derived xenograft models, 3‑D organoids and AI‑enhanced spectral flow cytometry to de‑risk next‑gen immunotherapies. Manufacturing focus...
Lest We "Off" Ourselves (Cautionary Examples)
Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and related injections from Dr. Adil Khan’s unregulated clinics. The series links Hyman’s spinal abscess and Peterson’s pneumonia‑sepsis to a pattern of...
Blueprint for Integrating Psilocybin Into NHS Mental Health Care
British Journal of Psychiatry Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin https://t.co/6sgfqg66rt
Did Eli Lilly Just Strike Another Gold Mine?
Eli Lilly announced a $1.5 billion acquisition of a biotech portfolio centered on orexin‑targeting therapeutics. The deal adds late‑stage candidates for insomnia, narcolepsy and metabolic disorders to Lilly’s central‑nervous‑system pipeline. Analysts estimate the combined market for orexin drugs could surpass $10 billion by...
First Human Trial Tests Cellular Age Reversal Therapy
This method to reverse cellular ageing is about to be tested in humans A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs. 💡"Technologies to refresh ageing tissue...
Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.
Novo Nordisk has rolled out Wegovy HD, a 7.2 mg weekly semaglutide injection, across the United States, delivering an average 20.7% weight loss in trials—significantly higher than the 2.4 mg dose. The FDA approved the product in March under its National Priority Review...
Locus FS Receives 2026 North American Technology Innovation Leadership Recognition
Frost & Sullivan has awarded Locus FS the 2026 North American Technology Innovation Leadership Recognition for its precision fermentation platform. The company’s proprietary microbial designs produce renewable glycolipid biosurfactants that replace petrochemical inputs across agriculture, oil and gas, mining, and industrial...
Stem Cell Therapy for Skin Rejuvenation: Safety, Benefits, and Recovery Time
Stem cell therapy is gaining traction as a non‑surgical skin‑rejuvenation option, leveraging the body’s own regenerative cells to boost collagen and elastin. Clinical reports suggest visible improvements in texture and firmness within two to three weeks, with full benefits emerging...
Yuviwel Gets FDA Greenlight as First Once‑Weekly Treatment for Dwarfism in Children
Ascendis Pharma’s Yuviwel (navepegritide) received FDA approval as the first once‑weekly therapy for achondroplasia in children aged two and older. The drug, a TransCon CNP formulation, showed a 1.5 cm greater annual height gain versus placebo in a 52‑week trial and...
The Road to Producing New Bodies Starts with Multi-Organ Pseudo-Embryos
Biotech researchers are moving from organoid cultures toward multi‑organ pseudo‑embryos that mimic early human development without brains. Companies such as R3 Bio and Kind Biotechnology are pioneering these brain‑less constructs as a bridge between tissue engineering and full‑body regeneration. The...
A Breath Test Reveals Infections Deep Inside Tissues
UCSF researchers have created a breath test that injects ^13C‑labeled sugars into the bloodstream, allowing bacteria deep in tissues to convert them into detectable ^13CO₂. In mouse models of muscle, bone, lung and bloodstream infections, the test identified infection within...
CSL Plans $1.5B Expansion of Illinois Plasma Therapy Manufacturing Facility
CSL announced a $1.5 billion expansion of its plasma‑therapy manufacturing plant in Kankakee, Illinois, aimed at boosting output of immunoglobulins, albumin and specialty proteins. The project will add at least 300 jobs to the existing 1,200‑person workforce and is expected to...
White House Adds AbbVie's Humira to TrumpRx Alongside Cheaper Biosimilars
The White House’s drug‑discount portal TrumpRx now lists AbbVie’s Humira at $950 per month, a steep cut from its typical $5,000‑plus price. The listing appears alongside two lower‑cost biosimilars that target the same inflammatory conditions. TrumpRx aims to provide seniors...
First In-Room MRI-Guided Breast Biopsy System Gets FDA Clearance
Mammotome received FDA clearance for the Prima MR system, the first in‑room MRI‑guided vacuum‑assisted breast biopsy platform, alongside its HydroMARK Plus MR biopsy site markers. The system lets clinicians perform biopsies directly inside the MRI suite, eliminating patient transfers and streamlining...
Growth Hormone Supplementation Can Restore the Thymus, but What Is Its Effect on Lifespan?
Recent debates on growth hormone (GH) supplementation highlight its ability to rejuvenate the thymus but raise serious concerns about lifespan effects. Experts from the 2013 Erice workshop and subsequent literature argue that while transient GH can restore immune tissue, chronic...
Pol Theta Enzyme Identified as Key Driver of Cancer Resilience
Researchers at Scripps Research discovered that the enzyme Pol θ mediates microhomology‑mediated end joining (MMEJ) directly at collapsed replication forks, overturning the previous belief that break‑induced replication (BIR) was the primary responder. Fork‑MMEJ, initiated by RPA, produces distinctive asymmetric deletions that...
Newly Developed Smart Molecules Offer a Safer and More Precise Approach to Cancer Care
Researchers at NYU Abu Dhabi have created manganese‑based smart molecules that act as both MRI contrast agents and cancer therapeutics. The compounds stay inert in healthy tissue and activate in the acidic micro‑environment of tumors, releasing manganese ions that enhance...
Outcomes of Treatment for Methicillin-Resistant Staphylococcus Aureus Ventilator-Associated Pneumonia
A retrospective study of 125 patients with MRSA‑associated ventilator‑associated pneumonia compared trimethoprim‑sulfamethoxazole (SMX‑TMP) to the standard vancomycin therapy. Mortality was 28% with SMX‑TMP versus 37% with vancomycin, a difference that was not statistically significant. Clinical cure rates at day 5 and...